Other publication
Quantitative drug sensitivity and resistance testing (DSRT) of primary ex vivo AML blasts highlights mTOR and MEK as potential key molecular driver signals of therapeutic significance
Authors: Pemovska T, Kylesskiy E, Kontro M, Szwajda A, Karjalainen R, Majumder MM, Malani D, Bespalov MM, Eldfors S, Elonen E, Knowles J, Murumagi A, Mpindi JP, Edgren H, Venkata NPK, Turunen L, Mustjoki S, Wolf M, Yadav B, Aittokallio T, Heckman CA, Porkka K, Kallioniemi O, Wennerberg K
Publisher: AMER ASSOC CANCER RESEARCH
Publication year: 2012
Journal: Cancer Research
Journal name in source: CANCER RESEARCH
Journal acronym: CANCER RES
Volume: 72
Number of pages: 1
ISSN: 0008-5472
DOI: https://doi.org/10.1158/1538-7445.AM2012-895